SELLAS Life Sciences Group, Inc. SLS Interest Income (Expense), Nonoperating
Interest Income (Expense), Nonoperating at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s interest income (expense), nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s interest income (expense), nonoperating?
- SELLAS Life Sciences Group, Inc. (SLS) reported interest income (expense), nonoperating of $845K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s interest income (expense), nonoperating changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s interest income (expense), nonoperating increased by 238.0% year-over-year, from $250K to $845K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s interest income (expense), nonoperating?
- Over 2 years (2023 to 2025), SELLAS Life Sciences Group, Inc.'s interest income (expense), nonoperating has grown at a 63.9% compound annual growth rate (CAGR), from $525K to $1.41M.